⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25288596 | 0.80 | — | — | |
| SCHEMBL21488083 | 0.79 | CHRM1 (0.34) | — | |
| SCHEMBL11348362 | 0.78 | — | — | |
| SCHEMBL24043682 | 0.78 | — | — | |
| SCHEMBL6931477 | 0.76 | CA12 (0.31) | — | |
| SCHEMBL6102651 | 0.76 | OPRK1 (0.38) | — | |
| SCHEMBL10367349 | 0.73 | CA12 (0.35) | — | |
| SCHEMBL7248068 | 0.73 | ALDH1A1 (0.41) | — | |
| SCHEMBL2690186 | 0.70 | — | — | |
| SCHEMBL126507 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1136474-B1 | 1-Acetyl-5-bromo-4,6-dimethylindoline | SANKYO CO (JP) | 2003-11-26 | — | — | EP | disclosed |
| EP-0782986-B1 | NOVEL HETEROCYCLIC DERIVATIVES, PROCESS FOR PRODUCING THE SAME, AND MEDICINAL USE THEREOF | SANKYO CO (JP) | 2003-07-02 | — | — | EP | disclosed |
| US-6489475-B2 | ENZYME INHIBITOR; LIPOPEROXIDATION INHIBITOR | SANKYO COMPANY, LIMITED (JP) | 2002-12-03 | — | — | US | disclosed |
| US-6414012-B1 | CARDIOVASCULAR DISORDERS; ANTICHOLESTEROL AGENTS | SANKYO COMPANY, LIMITED (JP) | 2002-07-02 | — | — | US | disclosed |
| EP-1136474-A1 | 1-Acetyl-5-bromo-4,6-dimethyl-indoline | SANKYO COMPANY LIMITED (JP) | 2001-09-26 | — | — | EP | disclosed |
| US-20010014740-A1 | Enzyme inhibitor; lipoperoxidation inhibitor | MATSUI HIROSHI (JP) | 2001-08-16 | — | — | US | disclosed |
| US-6127403-A | AN ENZYME INHIBITOR FOR TREATING ARTERIOSCLEROTIC LESIONS OF ARTERIOSCLEROSIS, HYPERLIPEMIA AND DIABETES, AS WELL AS ISCHEMIC DISEASES OF BRAIN, HEART | SANKYO COMPANY, LTD. (JP) | 2000-10-03 | — | — | US | disclosed |
| US-5990150-A | ACYLCOENZYME A:CHOLESTEROL ACYLTRANSFERASE (ACAT) INHIBITORS AND LIPOPEROXIDATION INHIBITORY ACTIVITY; ANTILIPEMIA; ARTERIOSCLEROSIS; ANTICHOLESTEROL AGENTS; ANTIISCHEMIC AGENTS; SIDE EFFECT REDUCTION | SANKYO COMPANY, LTD. (JP) | 1999-11-23 | — | — | US | disclosed |
| EP-0782986-A1 | NOVEL HETEROCYCLIC DERIVATIVES, PROCESS FOR PRODUCING THE SAME, AND MEDICINAL USE THEREOF | Kyoto Pharmaceutical Industries, Ltd. (JP) | 1997-07-09 | — | — | EP | disclosed |
| EP-0148883-B1 | ALLOPURINOL PRODRUGS | A/S GEA Farmaceutisk Fabrik (DK) | 1990-02-14 | — | — | EP | disclosed |
| US-4694006-A | Acyl- or acyloxymethyl-allopurinol prodrugs | A/S GEA (DK) | 1987-09-15 | — | — | US | disclosed |
| EP-0148883-A1 | ALLOPURINOL PRODRUGS. | GEA AS (DK) | 1985-07-24 | — | — | EP | disclosed |
| WO-1985000368-A1 | ALLOPURINOL PRODRUGS | A/S GEA (DK) | 1985-01-31 | — | — | WO | disclosed |